Sun Pharma agrees to acquire Checkpoint Therapeutics

Sun Pharmaceutical has agreed to acquire Checkpoint Therapeutics for an aggregate consideration of up to $355m upfront.

Mar 11, 2025 - 06:00

Sun Pharma agrees to acquire Checkpoint Therapeutics

Sun Pharmaceutical has agreed to acquire Checkpoint Therapeutics for an aggregate consideration of up to $355m upfront.

Read the original article

Tags:

Previous Article

EC approves BMS’ Opdivo and Yervoy combo for HCC

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

NephroDI Therapeutics and MSRD partner to develop therapy for NDI

NephroDI Therapeutics and MSRD partner to develop thera...

Jun 23, 2023

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan...

Oct 20, 2024

Cidara buys back rights to flu therapy from J&J for $85m

Cidara buys back rights to flu therapy from J&J for $85m

Apr 27, 2024